RAPID MEDICAL DIAGNOSTIC KITS MARKET ANALYSIS

Rapid Medical Diagnostic Kits Market, By Test Type (Blood glucose monitoring test kits, Pregnancy test kits, Infectious disease test kits, Coagulation monitoring test kits, Others), By Sample Type Blood tests, Urine tests, Saliva tests, Others), By End User (Hospitals and clinics, Home care settings, Diagnostic laboratories), By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Recent Developments:

New product launches:

On February 23, 2023, Mylab Discovery Solutions, which offers rapid diagnostic kits, announced that it had expanded its portfolio of rapid tests for sexually transmitted diseases (STIs), namely HIV, HCV and Syphilis.
On October 12, 2022, Roche, a pharmaceutical company, announced the launch of SARS-CoV-2 rapid antigen tests for self-testing and professional use in countries accepting the CE Mark.

Acquisition and Partnerships:

On August 17, 2023, CrisprBits, a biotech startup, announced that is had formed a strategic collaboration with MolBio Diagnostics to launch CRISPR-based point-of-care tests.